IMO the Occam’s razor explanation is this:
NWBO is a tiny cash strapped biotech trading on the OTC.
NWBO has taken 3-5X longer for everything from the trial, to data lock, to TLD, to publication, to MIA, to manufacturing buildout, to Flaskworks development, to MAA application, and now to MAA approval.
We know for a FACT that the CHM advised on MAA approval on 11/28/2025.
We know that for complex biologics like DCVAX, the time between CHM opinion and MAA decision is around 3 months.
So the simplest explanation is that we will receive an MAA decision on the original MAA that was filed (artisanal manufacturing, GBM only, etc.) on or around 2/28/2026
Not world cancer day, not agnostic, not Flaskworks, not secret FDA approval.
I could care less if I get no likes and block every single illogical basher and pumper on this board. I choose to live in reality as I have much of my life savings invested in this company for the past 11 years.
Market Data 
Markets 
